Cell Line : OV17R
Cellosaurus Index : CVCL_2672
Cellosaurus ID : OV17R
GDSC1 Name
, GDSC2 Name
: OV-17R
CCLE Name
: OV17R_OVARY
Cancer Type : urogenital_system
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| OV17R | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | 5-Fluorouracil | GDSC1,GDSC2 | 0.0200 | 32.0000 |
|
| OV17R | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | A-83-01 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | ABT737 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | Afatinib | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| OV17R | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | AGI-6780 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| OV17R | AGK-2 | GDSC2 | 0.0040 | 4.0000 |
|
| OV17R | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| OV17R | AKT inhibitor VIII | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | Alectinib | GDSC1 | 0.0200 | 5.1200 |
|
| OV17R | Alisertib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Alpelisib | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Amuvatinib | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | AR-42 | GDSC1 | 0.0200 | 5.1200 |
|
| OV17R | Ara-G | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| OV17R | AS605240 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | AT13148 | GDSC2 | 0.0080 | 8.0000 |
|
| OV17R | AT7867 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.2400 |
|
| OV17R | Axitinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| OV17R | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | AZD1208 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | AZD1332 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| OV17R | AZD2014 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| OV17R | AZD4547 | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| OV17R | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| OV17R | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | AZD5438 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| OV17R | AZD6482 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | AZD7762 | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| OV17R | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | AZD8055 | GDSC1 | 0.0078 | 2.0000 |
|
| OV17R | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| OV17R | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | BAY-MPS-combo 2 (paclitaxel 1 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| OV17R | BAY-MPS-combo-1 (paclitaxel 5 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| OV17R | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| OV17R | Belinostat | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | BI-2536 | GDSC2 | 0.0005 | 0.5000 |
|
| OV17R | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | BIBR-1532 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Bicalutamide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | BIX02189 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | Bleomycin (50 uM) | GDSC1 | 0.1953 | 50.0000 |
|
| OV17R | BMS-345541 | GDSC1,GDSC2 | 0.0100 | 16.0000 |
|
| OV17R | BMS-536924 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | BMS-754807 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Bortezomib | GDSC2 | 0.0000 | 0.0200 |
|
| OV17R | Bosutinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| OV17R | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | BX795 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | Cabozantinib | GDSC1 | 0.0200 | 5.1200 |
|
| OV17R | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| OV17R | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| OV17R | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| OV17R | CAY10603 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | CCT-018159 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| OV17R | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| OV17R | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| OV17R | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| OV17R | CHIR-99021 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | Cisplatin | GDSC1 | 0.0117 | 10.0000 |
|
| OV17R | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| OV17R | CP724714 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| OV17R | Crizotinib | GDSC2 | 0.0040 | 8.0000 |
|
| OV17R | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | CUDC-101 | GDSC1 | 0.0200 | 5.1200 |
|
| OV17R | CX-5461 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | Cyclophosphamide | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Cytarabine | GDSC1 | 0.0078 | 2.0000 |
|
| OV17R | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Dabrafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Dactinomycin | GDSC2 | 0.0008 | 0.8000 |
|
| OV17R | Dactolisib | GDSC1,GDSC2 | 0.0003 | 0.2500 |
|
| OV17R | Daporinad | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| OV17R | Dasatinib | GDSC2 | 0.0020 | 2.0000 |
|
| OV17R | Dinaciclib | GDSC2 | 0.0010 | 1.0000 |
|
| OV17R | Docetaxel | GDSC1,GDSC2 | 0.0000 | 0.0125 |
|
| OV17R | Doramapimod | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Doxorubicin | GDSC1 | 0.0195 | 5.0000 |
|
| OV17R | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Elesclomol | GDSC1,GDSC2 | 0.0002 | 0.2000 |
|
| OV17R | Entinostat | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Enzastaurin | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | Epirubicin | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Erlotinib | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | Fedratinib | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| OV17R | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| OV17R | Foretinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | FR-180204 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| OV17R | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | Fulvestrant | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| OV17R | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Gefitinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| OV17R | Gemcitabine | GDSC1,GDSC2 | 0.0002 | 10.0000 |
|
| OV17R | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| OV17R | GSK1059615 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | GSK1070916 | GDSC1 | 0.0100 | 2.5600 |
|
| OV17R | GSK1904529A | GDSC2 | 0.0050 | 5.0000 |
|
| OV17R | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | GSK269962A | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | GSK343 | GDSC2 | 0.0010 | 1.0000 |
|
| OV17R | GSK429286A | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | GSK690693 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | GW-2580 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| OV17R | HG-5-113-01 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | HG-5-88-01 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | I-BET-762 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| OV17R | I-BET151 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | IAP_5620 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | Ibrutinib | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | IC-87114 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | Idelalisib | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | IOX2 | GDSC1,GDSC2 | 0.0004 | 0.5000 |
|
| OV17R | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Irinotecan | GDSC2 | 0.0050 | 5.0000 |
|
| OV17R | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| OV17R | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| OV17R | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | JQ1 | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| OV17R | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | KIN001-236 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | KIN001-244 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | KIN001-260 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | KIN001-266 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | KIN001-270 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| OV17R | KU-55933 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | KU-60019 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | Lapatinib | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | LCL161 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | LDN-193189 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| OV17R | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| OV17R | LGK974 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | Linifanib | GDSC1 | 0.0040 | 1.0240 |
|
| OV17R | Linsitinib | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Luminespib | GDSC2 | 0.0003 | 0.2500 |
|
| OV17R | LY2109761 | GDSC2 | 0.0050 | 5.0000 |
|
| OV17R | Masitinib | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| OV17R | Methotrexate | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| OV17R | MG-132 | GDSC2 | 0.0040 | 4.0000 |
|
| OV17R | MIM1 | GDSC1 | 0.1562 | 40.0000 |
|
| OV17R | MIRA-1 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Mirin | GDSC1,GDSC2 | 0.1001 | 100.0000 |
|
| OV17R | MK-1775 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | MK-2206 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| OV17R | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| OV17R | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| OV17R | MPS-1-IN-1 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | Navitoclax | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| OV17R | NG-25 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | Nilotinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| OV17R | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | NPK76-II-72-1 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | NSC-207895 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | NSC319726 | GDSC1 | 0.0010 | 0.2560 |
|
| OV17R | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| OV17R | Nutlin-3a | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | NVP-ADW742 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | NVP-BHG712 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Olaparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Omipalisib | GDSC1 | 0.0005 | 0.1280 |
|
| OV17R | OSI-027 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| OV17R | OSI-930 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| OV17R | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Oxaliplatin | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Paclitaxel | GDSC2 | 0.0001 | 0.1000 |
|
| OV17R | Palbociclib | GDSC1,GDSC2 | 0.0040 | 4.0000 |
|
| OV17R | Panobinostat | GDSC1 | 0.0040 | 1.0240 |
|
| OV17R | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| OV17R | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| OV17R | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| OV17R | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | PD0325901 | GDSC1,GDSC2 | 0.0010 | 2.5000 |
|
| OV17R | PD173074 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| OV17R | Pelitinib | GDSC1 | 0.0098 | 2.5000 |
|
| OV17R | Pemetrexed | GDSC1 | 0.0100 | 2.5600 |
|
| OV17R | Pevonedistat | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| OV17R | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | PF-4708671 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | PFI3 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | PHA-793887 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | Phenformin | GDSC1 | 15.6250 | 4000.0000 |
|
| OV17R | PI-103 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Pictilisib | GDSC1,GDSC2 | 0.0040 | 4.0000 |
|
| OV17R | PIK-93 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | Piperlongumine | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| OV17R | PLX-4720 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | PRIMA-1MET | GDSC2 | 0.0300 | 30.0000 |
|
| OV17R | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | QL-VIII-58 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | QL-X-138 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | QL-XII-47 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | QL-XII-61 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | Quizartinib | GDSC1 | 0.0040 | 1.0240 |
|
| OV17R | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | Rapamycin | GDSC2 | 0.0001 | 0.1000 |
|
| OV17R | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| OV17R | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| OV17R | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| OV17R | Ruxolitinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Sapitinib | GDSC2 | 0.0050 | 5.0000 |
|
| OV17R | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| OV17R | SB216763 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | SB505124 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| OV17R | SB52334 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| OV17R | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| OV17R | Selisistat | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | Selumetinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Sepantronium bromide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Serdemetan | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| OV17R | SL0101 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | SN-38 | GDSC1,GDSC2 | 0.0002 | 10.0000 |
|
| OV17R | SNX-2112 | GDSC1 | 0.0100 | 2.5600 |
|
| OV17R | Sorafenib | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Sphingosine Kinase 1 Inhibitor II | GDSC1 | 0.0100 | 2.5600 |
|
| OV17R | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| OV17R | STF-62247 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | SU11274 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | T0901317 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | TAK-715 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Tamoxifen | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Tanespimycin | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| OV17R | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| OV17R | Taselisib | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Telomerase Inhibitor IX | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Temozolomide | GDSC1,GDSC2 | 0.0300 | 30.0000 |
|
| OV17R | Temsirolimus | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| OV17R | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | THZ-2-102-1 | GDSC1 | 0.0098 | 2.5000 |
|
| OV17R | THZ-2-49 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | Tivozanib | GDSC1 | 0.0005 | 0.1280 |
|
| OV17R | TL-1-85 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | TL-2-105 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | Tozasertib | GDSC2 | 0.0050 | 5.0000 |
|
| OV17R | TPCA-1 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | Trametinib | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| OV17R | Tretinoin | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| OV17R | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | Tubastatin A | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | TW 37 | GDSC1 | 0.0195 | 5.0000 |
|
| OV17R | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | Ulixertinib | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | UNC0638 | GDSC1 | 0.0781 | 40.0000 |
|
| OV17R | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| OV17R | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| OV17R | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| OV17R | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Veliparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| OV17R | Venotoclax | GDSC1 | 0.0010 | 0.2560 |
|
| OV17R | Vinblastine | GDSC1 | 0.0004 | 0.1000 |
|
| OV17R | Vinorelbine | GDSC2 | 0.0001 | 0.1000 |
|
| OV17R | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | VNLG-124 | GDSC1 | 0.0200 | 5.1200 |
|
| OV17R | Vorinostat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | VX-11e | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| OV17R | Wee1 Inhibitor | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | WHI-P97 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | Wnt-C59 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | WZ3105 | GDSC1 | 0.0050 | 1.2800 |
|
| OV17R | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | XAV939 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| OV17R | XMD11-85h | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | XMD13-2 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | XMD14-99 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | XMD15-27 | GDSC1 | 0.0400 | 10.2400 |
|
| OV17R | XMD8-92 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | Y-39983 | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | YK-4-279 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | YM201636 | GDSC1 | 0.0200 | 5.1200 |
|
| OV17R | ZG-10 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | Zibotentan | GDSC1 | 0.0781 | 20.0000 |
|
| OV17R | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| OV17R | ZM447439 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| OV17R | ZSTK474 | GDSC1 | 0.0200 | 5.1200 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC